Slyntvatl
/ Adaptimmune, Cardiff University, University of Pennsylvania
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 16, 2019
Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
(PubMed, AIDS)
- "Our data explore the hypothesis that poorly recognized epitope variants not only facilitate HIV-1 evasion of CTL recognition, but also induce CTL dysfunction through suboptimal signaling causing anergy. However, the results do not suggest that suboptimal signaling induces anergy (or exhaustion or apoptosis), indicating that the major role of CTL epitope variation is likely viral escape."
Journal • Gene Therapies • Human Immunodeficiency Virus • Infectious Disease
1 to 1
Of
1
Go to page
1